Rational development of a HIV-1 gene therapy vector

Area of Science:

• Molecular Biology
• Virology
• Gene Therapy

Background:

• Human immunodeficiency virus type 1 (HIV-1) is a promising basis for gene transfer vectors due to its ability to transduce non-cycling cells.
• Understanding the impact of viral cis elements on vector function is crucial for maximizing HIV-1 vector potential.

Purpose of the Study:

• To systematically evaluate the effects of various HIV-1 cis sequence elements on gene vector production efficiency (titer and infectivity).
• To assess the safety of different vector designs by measuring the potential for inadvertent transfer of the gagpol gene.
• To identify and construct an optimized HIV-1 vector with improved characteristics.

Main Methods:

• Systematic evaluation of cis elements from the HIV-1 YU-2 genome.
• Assessment of vector production efficiency, including titer and infectivity.
• Analysis of gagpol gene transfer to transduced cells as a safety measure.
• RNA analysis to investigate the role of the Rev/RRE system.

Main Results:

• Specific sequences, including those from the 5' gag, 5' and 3' env genes, and the polypurine tract, increased vector titer.
• Substitution or deletion of the HIV-1 Rev-responsive element (RRE) significantly reduced vector titers.
• RNA analysis indicated the Rev/RRE system has functions beyond nuclear export.
• An optimal vector construct with enhanced safety characteristics was identified.

Conclusions:

• An optimized HIV-1 vector was constructed, demonstrating superior efficiency and safety compared to the widely used pHR' vector.
• The study delineates critical cis elements for enhancing HIV-1 vector performance.
• Findings contribute to the development of safer and more effective gene transfer vectors.